Suppr超能文献

眼睑肿瘤和假瘤的糖病理学研究

Glycopathological study of eyelid tumors and pseudotumors.

作者信息

Uehara F, Yonezawa S, Sato E, Ohba N

机构信息

Department of Opthalmology, Kagoshima University Faculty of Medicine, Japan.

出版信息

Jpn J Ophthalmol. 1997 Nov-Dec;41(6):362-9. doi: 10.1016/s0021-5155(97)00075-0.

Abstract

The expression of MUC1, Tn (GalNAc alpha 1-O-Ser/Thr) and sialosyl Tn (STn) (NeuAc alpha 2,6 GalNAc alpha 1-O-Ser/Thr) antigens, which are useful markers for the prognosis of cancer in other organs, was examined immunohistochemically in a series of 45 eyelid tumors and 5 pseudotumors: basal cell carcinoma, 18; squamous cell carcinoma, 11; sebaceous gland carcinoma, 6; seborrheic keratosis, 4; papilloma, 3; verruca vulgaris, 2; nevus, 1; and granuloma, 5. The MUC1 antigen was identified in all squamous cell and sebaceous gland carcinomas, but not in basal cell carcinoma or the benign tumors. The Tn antigen was expressed in all the sebaceous gland, half of the squamous cell, and only rarely in the basal cell carcinomas. The STn antigen was expressed in all seborrheic keratosis and in the majority of squamous cell carcinomas, but only rarely in sebaceous gland and basal cell carcinomas. Eyelid tumors are frequently associated with apomucin and mucin-carbohydrate antigens: the MUC1 glycoprotein appears to be related to the malignant potential of eyelid tumors, and may be a useful marker for the differential diagnosis of invasive tumors, including sebaceous gland and squamous cell carcinomas.

摘要

MUC1、Tn(GalNAcα1 - O - Ser/Thr)和唾液酸化Tn(STn)(NeuAcα2,6 GalNAcα1 - O - Ser/Thr)抗原的表达在一系列45例眼睑肿瘤和5例假瘤中进行了免疫组织化学检测,这些抗原在其他器官中是癌症预后的有用标志物:基底细胞癌18例;鳞状细胞癌11例;皮脂腺癌6例;脂溢性角化病4例;乳头状瘤3例;寻常疣2例;痣1例;肉芽肿5例。MUC1抗原在所有鳞状细胞癌和皮脂腺癌中均有发现,但在基底细胞癌或良性肿瘤中未发现。Tn抗原在所有皮脂腺癌、一半的鳞状细胞癌中表达,在基底细胞癌中仅偶尔表达。STn抗原在所有脂溢性角化病和大多数鳞状细胞癌中表达,但在皮脂腺癌和基底细胞癌中仅偶尔表达。眼睑肿瘤常与脱辅基粘蛋白和粘蛋白 - 碳水化合物抗原相关:MUC1糖蛋白似乎与眼睑肿瘤的恶性潜能有关,可能是包括皮脂腺癌和鳞状细胞癌在内的浸润性肿瘤鉴别诊断的有用标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验